(Updated 2/2 to include site location.)
ROXBURY, NJ – A British pharmaceuticals company has chosen Roxbury as the site of its new United States headquarters, it was announced today.
The company, BAP Pharma, said it will establish its new American base of operations on Orben Drive in Landing. It said the Roxbury site will be its first location in the USA.
BAP supplies comparators for clinical trials, managing the process of supplying materials for those trials. It said this process includes sourcing, delivery and customized solutions “to provide seamless service to its clients.”
BAP said its clients include some of the United Kington’s major pharmaceutical companies.
In a statement, BAP Managing Director Dr. Bashir Parkar said the company chose the Roxbury site in response to BAP’s rapid growth. He said pharmaceutical industry veteran Lucas Nigro will manage the U.S. headquarters.
“Since 2011, BAP Pharma has been establishing itself as a global leader in the clinical trial supply sector based on attention to quality and best-in-class client service,” said Parkar. “The opening of our U.S. headquarters in New Jersey is an important milestone for our company and will enhance our ability to provide fast, seamless service to our clients.”
Parkar visited the site last year, according to Choose New Jersey, Inc., a non-profit economic development organization that attempts to convince companies to settle in New Jersey. “BAP Pharma chose to lease a facility in Landing, which it has equipped with state of the art, fully enclosed temperature controlled ambient and cold room storage facilities,” said Choose New Jersey. It did not specify the address of the building.
“The facility and location proved a perfect fit for our company,” said Parkar. “Its proximity to a significant number of global pharmaceutical and biotechnology companies, including our current clients, made it particularly attractive. New Jersey’s excellent transportation network also enhances our ability to deliver products quickly and efficiently throughout the region and around the world.”
“We are excited to welcome BAP Pharma to the State’s thriving life sciences community,” said Michele Brown, president and CEO of Choose New Jersey. “Like New Jersey, the UK is a global leader in the life sciences. We’ve established strategic relations in this market through business trips and lead generation activities."
Brown said New Jersey is "ideally positioned to be the landing pad for international firms, based on its location in the heart of the Northeast, its diverse and talented labor pool, and the presence of the world’s top pharma and biotech companies.”
BAP Pharma said it will celebrate with an official ribbon cutting ceremony this spring. The company said its U.S. arm currently has two employees but plans to hire "at least three more during the year to meet customer needs."